US · Healthcare · Medical Devices
EPS came in at 0.73 against a street estimate of 0.73 — a beat of 0.0%.
Analysts rate Boston Scientific Corp a buy (21 buy, 10 hold, 0 sell out of 31) with an average price target of $49.60.
CAUTIOUS Cyber disruption, EP share losses, WATCHMAN weakness and China pricing pressure drove a sharp reset. Management expects 2027 to be a trough, with launches and restructuring supporting recovery from 2028. Q3 FY26 U.S. performance was flat operationally; EMEA grew 6%; Asia Pacific declined 1% amid cyber disruption and China pricing pressure. Analysts pressed management on the cyber impact, 2027 weakness, delayed pipeline launches, restructuring and confidence in 2028 recovery. Management emphasized inventory normalization, ongoing EP and WATCHMAN pressure, tighter forecasting and future launches. 2026-10-28…
Full summary in the app.
| Fund | Stake |
|---|---|
| BlackRock Inc | 8.95% |
| Vanguard Capital Management, LLC | 6.70% |
| State Street Corp | 4.84% |
| PRIMECAP Management Company | 3.49% |
| FMR Inc | 3.15% |
| Geode Capital Management, LLC | 2.31% |
| Vanguard Portfolio Management, LLC | 2.06% |
| D. E. Shaw & Co LP | 1.76% |
| Document | Date |
|---|---|
| Quarterly report · Q3 2026 HEADLINE NUMBERS • Third-quarter 2026 net sales were $5,138 million, compared with $5,065 million in the third quarter of 2025. • Nine-month 2026 ne | 2026-11-02 |
| Results announced · Q4 2026 HEADLINE NUMBERS • Third-quarter 2026 net sales were $5.138 billion, up 1.5% on reported, operational and organic bases versus the prior year. • GAA | 2026-10-28 |
| Board / officer change · Q4 2026 HEADLINE NUMBERS • Boston Scientific announced executive leadership changes in an October 7, 2026 Form 8-K. • Joe Fitzgerald, age 63, will become Ex | 2026-10-07 |
| Board / officer change · Q3 2026 BOSTON SCIENTIFIC CORPORATION – FORM 8-K SUMMARY September 21, 2026 --- HEADLINE NUMBERS • Executive Departure Date: Arthur C. Butcher retiring as | 2026-09-23 |
| Current report · Q3 2026 BOSTON SCIENTIFIC CORPORATION – FORM 8-K SUMMARY HEADLINE NUMBERS • Cybersecurity incident detected August 25, 2026; disclosed September 7, 2026 • C | 2026-09-08 |
| Company announcement · Q3 2026 BOSTON SCIENTIFIC CORPORATION - FORM 8-K SUMMARY HEADLINE NUMBERS • Cybersecurity incident identified on August 25, 2026 • Global disruption to compa | 2026-08-26 |
| Quarterly report · Q2 2026 BOSTON SCIENTIFIC CORPORATION - Q2 2026 10-Q SUMMARY HEADLINE NUMBERS • Q2 2026 net sales: $5,442 million (up 7.5% vs Q2 2025: $5,061 million) • H1 | 2026-08-03 |
| Results announced · Q3 2026 BOSTON SCIENTIFIC Q2 2026 EARNINGS SUMMARY HEADLINE NUMBERS • Q2 2026 net sales: $5.442 billion, up 7.5% reported / 7.0% operational and organic vs. | 2026-07-29 |
Readable in the app.
| Announcement | Date |
|---|---|
| Cybersecurity incident likely to cause material impact on 2026 guidance Boston Scientific Corporation suffered a significant cybersecurity incident on August 25, 2026, that caused a global operational disruption. Unauthorized activity on the company's systems re | 2026-09-08 |
| Investment agreement to acquire stake in MiRus LLC with call option for full acquisition Boston Scientific announced a major strategic investment in MiRus LLC, a private company developing a novel transcatheter aortic valve replacement (TAVR) system. The deal structure includes: | 2026-05-18 |
| Accelerated share repurchase program of $2 billion announced Boston Scientific announced a $2 billion accelerated share repurchase (ASR) program with JPMorgan Chase on May 18, 2026. The company will immediately receive approximately 30.4 million share | 2026-05-18 |
| Entered into Agreement and Plan of Merger with another company Boston Scientific announced on January 14, 2026, that it will acquire Penumbra, Inc., a medical device company, through a merger. Under the deal, Penumbra shareholders can choose to receive | 2026-01-15 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Boston Scientific Corp — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-11-07.